Past Issues
Heart Disease and Depression
Hiroto Ito, Yasuyuki Okumura, Hiroyuki Yokoyama
Depression is common in patients with physical illness. The National Center
of Neurology and Psychiatry has launched a joint project with five other centers in
Japan, aiming at improving the quality of mental care in patients with physical ill-
ness. In the present overview focusing on heart disease, we review the prevalence
of depression in patients with heart disease, the impact of depression on cardiac
prognosis, the possible mechanisms of depression in patients with heart disease,
drug-drug interactions between cardiac and psychotropic agents and the possible
therapeutic approaches to treating these patients. Depression and heart disease of-
ten coexist and each can lead to the other. Various biological and behavioral mech-
anisms have been proposed to explain an association between heart disease and
depression, including autonomic nervous system activity, impairment of platelet
function, endothelial dysfunction, inflammatory changes, and health-related be-
haviors. Combination therapy with tricyclic antidepressant and cardiac agents
must be approached with caution to avoid drug-drug interactions. Selective sero-
tonin reuptake inhibitors (SSRIs) are the first line treatment for patients with heart
disease and moderate to severe depression. Although no single intervention has
been established as the standardized treatment, recent studies suggest that collab-
orative care improves both depressive symptoms and cardiac outcomes, and that
patient’s participation is a key to successful treatment. Bridging the gap between
cardiology and psychiatry is essential, and psychiatrists can play a vital role in tak-
ing care of the mental health of patients with heart disease.
Key Word | depression, heart disease, antidepressant, collaborative care |
---|